| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
24,155 |
22,745 |
$4.77M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,503 |
12,923 |
$2.64M |
| G0378 |
Hospital observation service, per hour |
387 |
339 |
$327K |
| T1015 |
Clinic visit/encounter, all-inclusive |
1,152 |
339 |
$247K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,476 |
1,381 |
$221K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
461 |
455 |
$133K |
| 76830 |
Ultrasound, transvaginal |
372 |
367 |
$110K |
| 73564 |
|
431 |
409 |
$100K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
450 |
439 |
$86K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
347 |
339 |
$71K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,407 |
2,979 |
$62K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,009 |
978 |
$57K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
286 |
272 |
$48K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,472 |
2,111 |
$41K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,117 |
4,552 |
$40K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,056 |
1,897 |
$38K |
| 80053 |
Comprehensive metabolic panel |
3,105 |
2,787 |
$30K |
| 71046 |
Radiologic examination, chest; 2 views |
746 |
716 |
$27K |
| 70450 |
Computed tomography, head or brain; without contrast material |
599 |
551 |
$25K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,515 |
1,432 |
$25K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
459 |
454 |
$24K |
| 87631 |
|
509 |
501 |
$22K |
| 73630 |
|
305 |
300 |
$21K |
| 76642 |
|
112 |
112 |
$19K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
56 |
54 |
$19K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,461 |
6,492 |
$18K |
| 73130 |
|
190 |
178 |
$13K |
| 73030 |
|
184 |
178 |
$12K |
| 77066 |
Tomosynthesis, mammo |
39 |
39 |
$12K |
| 73610 |
|
194 |
182 |
$12K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
18 |
17 |
$12K |
| 85027 |
|
255 |
250 |
$12K |
| 81025 |
|
1,996 |
1,852 |
$11K |
| 93971 |
|
68 |
63 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
473 |
454 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
1,825 |
1,642 |
$9K |
| 84484 |
|
2,516 |
2,220 |
$8K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
81 |
79 |
$8K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
50 |
50 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
805 |
753 |
$7K |
| 85610 |
|
734 |
678 |
$7K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
15 |
13 |
$7K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
455 |
437 |
$7K |
| 77065 |
Tomosynthesis, mammo |
28 |
25 |
$7K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,280 |
1,142 |
$7K |
| J7050 |
Infusion, normal saline solution, 250 cc |
896 |
659 |
$6K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
100 |
94 |
$6K |
| 82962 |
|
955 |
739 |
$6K |
| 73110 |
|
73 |
71 |
$6K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
254 |
241 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
775 |
697 |
$5K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
389 |
324 |
$5K |
| 72100 |
|
90 |
83 |
$5K |
| 97161 |
|
36 |
35 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
816 |
674 |
$4K |
| 87210 |
|
240 |
234 |
$4K |
| 85730 |
|
350 |
332 |
$4K |
| 0011A |
|
148 |
148 |
$4K |
| 86900 |
|
280 |
263 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
334 |
314 |
$4K |
| 81001 |
|
1,719 |
1,599 |
$4K |
| 81003 |
|
680 |
637 |
$3K |
| 94060 |
|
14 |
14 |
$3K |
| 83735 |
|
1,486 |
1,250 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
108 |
99 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,317 |
1,261 |
$3K |
| 0012A |
|
104 |
103 |
$3K |
| 73502 |
|
58 |
56 |
$3K |
| 83690 |
|
951 |
894 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
12 |
12 |
$2K |
| 82248 |
|
454 |
427 |
$2K |
| 94726 |
|
14 |
14 |
$2K |
| 94729 |
|
13 |
13 |
$2K |
| 77062 |
|
24 |
24 |
$1K |
| 84702 |
|
117 |
95 |
$1K |
| 83605 |
|
391 |
362 |
$1K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
49 |
47 |
$1K |
| 83880 |
|
109 |
102 |
$1K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
49 |
49 |
$1K |
| 87077 |
|
144 |
136 |
$1K |
| 96376 |
|
176 |
138 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
133 |
123 |
$1K |
| 85379 |
|
238 |
223 |
$1K |
| 87430 |
|
48 |
47 |
$941.60 |
| 90715 |
|
46 |
41 |
$702.06 |
| 73080 |
|
12 |
12 |
$631.94 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
336 |
277 |
$609.47 |
| 86850 |
|
146 |
136 |
$606.36 |
| 87040 |
|
64 |
60 |
$477.68 |
| 82550 |
|
206 |
177 |
$458.17 |
| 86901 |
|
219 |
204 |
$458.03 |
| J3490 |
Unclassified drugs |
836 |
607 |
$436.68 |
| 87186 |
|
125 |
119 |
$430.08 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
15 |
15 |
$415.50 |
| 90686 |
|
42 |
41 |
$370.13 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,911 |
1,732 |
$348.85 |
| 84100 |
|
248 |
182 |
$346.14 |
| 82800 |
|
72 |
69 |
$331.81 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,602 |
1,408 |
$310.17 |
| G0008 |
Administration of influenza virus vaccine |
47 |
46 |
$221.21 |
| J2704 |
Injection, propofol, 10 mg |
371 |
329 |
$184.75 |
| 87081 |
|
42 |
41 |
$156.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
501 |
443 |
$141.82 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
634 |
555 |
$132.86 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
440 |
351 |
$108.07 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
104 |
94 |
$104.80 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
461 |
422 |
$100.80 |
| 36415 |
Collection of venous blood by venipuncture |
30 |
29 |
$95.20 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
128 |
120 |
$88.20 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
20 |
14 |
$61.45 |
| J1630 |
Injection, haloperidol, up to 5 mg |
52 |
40 |
$47.10 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
320 |
297 |
$40.01 |
| 87147 |
|
13 |
13 |
$39.00 |
| 87205 |
|
28 |
24 |
$37.36 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
143 |
83 |
$28.74 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
429 |
304 |
$8.33 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
221 |
195 |
$7.76 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
14 |
12 |
$4.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
68 |
59 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
93 |
85 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
178 |
132 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
85 |
80 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
25 |
25 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
30 |
14 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
30 |
19 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
27 |
26 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
57 |
48 |
$0.00 |
| 00000 |
|
560 |
314 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
18 |
15 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
33 |
29 |
$0.00 |